Letter to Senate: Support for the Food and Drug Administration Safety Act of 2005

The Safety Act corrects the most serious problem in FDA’s drug safety program—its passive and feeble postmarket safety monitoring system that turns millions of trusting consumers into guinea pigs testing unresolved safety problems. The FDA Safety Act, by creating a strong and independent Center for Post-market Drug Evaluation and Research, will reassure Americans that drug safety will be a top priority at the FDA.